- Market-level data points include sales revenue, sales unit volume and average selling price
- Data file: historical global market-level data for calendar years 2018 and 2020
- Data file: a 5-year global market-level forecast for calendar years 2021 to 2025
- PDF report: analyst commentary on growth trends and the factors driving market growth
This report is designed to offer our clients accurate and credible global market sales data for x-ray detectors for use within medical mobile C-arm x-ray imaging systems. Market data is segmented by detector technology and major geographical region in order to provide a comprehensive and insightful view of the global market. Where possible, historical sales data is reported to PMI by individual OEMs under non-disclosure agreements. This data is used to calculate a historical aggregate global market size by calendar year. In lieu of OEM reported data, PMI uses a propriety autoregressive statistical model to estimate sales data. Alongside this historical data, an annual global sales forecast is generated using a combination of quantitative statistical modelling as well as discussions with senior industry executives in order to capture their market outlooks and specific industry trends. Complementing the historical and forecasted datasets is a written report containing detailed analyst commentary on the growth trends and the factors driving the market growth. This report is designed for executives working within the x-ray imaging sector, particularly those working within a market intelligence, product management, strategy, marketing or investment function.
- The replacement of CCD and image intensifier technology with FPD technology.
- The dynamics and trade-offs between CMOS, a-Si TFT and IGZO TFT detector technologies.
- The adoption and growth of CMOS and IGZO TFT technologies.
Proposed Data Segmentation
Market data points are anticipated to be segmented by industry vertical, product group, detector technology and geographical region. The drivers of sales growth by each segment will be discussed within the summary report. The OEM’s collaborating with PMI have the opportunity to suggest changes to the proposed data specification up to the 30th April 2021.
|Industry||Product Segment||Geographical Region|
|Asia & Oceania|
The Sankey diagram below demonstrates the anticipated market data segmentation. Within the output of the report, each node on the Sankey diagram will represent either sales revenue or sales unit volumes, depending on the data view selected.
Example Graph Outputs
Following the discovery of the charge-coupled device (CCD) in the late 1960s, CCD image sensors combined with image intensifiers (II) quickly became the defacto technology for dynamic digital medical imaging systems. CCD-II-based technology offered a superior option for dynamic imaging compared with the standard screen-film alternatives as the technology delivered significantly greater x-ray sensitivity at a much lower radiation dose. The synergy of high sensitivity and high conversion efficiency during fluoroscopy remains one of the biggest advantages of CCD-II technology and it is still widely used in medical c-arm systems today. It wasn’t until the arrival of flat panel detector (FPD) technology when CCD-II technology began being partially displaced. During the 2000s, innovative C-arm system manufacturers began integrating FPDs using amorphous silicon (a-Si) thin-film transistors (TFT) in their systems. FPD technology increased the utility of medical C-arm systems through improved image quality, better patient coverage from an increased field of view (FOV) as well as enhancing system usability and operator workflow. The lower electronic noise and reduced image distortion from a-Si TFT offers significantly improved image quality, especially when combined with powerful software algorithms for image reconstruction and optimization. In addition, the integration of an FPD over CCD-II requires smaller detector housing which reduces the size and profile of C-arm systems. This technology is now mature as a-Si TFT FPDs can be fabricated at low cost using the direct deposit of cesium iodide (CsI) which delivers better light collection efficiency and performance. Although a-Si TFT FPDs have many advantages the current generation of detectors continue to be limited by the performance of the TFT. The low electron mobility of a-Si requires large TFTs with high stray capacitance, which increases electronic noise and reduces the pixel fill factor. This negatively impacts the signal-to-noise ratio (SNR) and therefore inherently limits the image quality. In areas where a-Si TFT performance is constrained, complementary metal–oxide–semiconductor (CMOS) technology was introduced as it can offer material advantages in performance over a-Si TFT including improved resolution, electronic noise performance and speed. As a result, CMOS FPDs have also gained steady acceptance as system integrators and OEMs have re-evaluated which technology delivers an optimal balance between cost and performance for the clinical setting. Despite its performance advantages, the increased cost and complexity of manufacture has been a limiting factor for CMOS adoption. Since CMOS sensors are fabricated on wafers and therefore constrained to the wafer size, mechanical tiling of multiple CMOS sensors onto a fibre optic plate is required in order to achieve a larger field of view. Today, the majority of sales revenue generated from the sale of medical C-arm systems deploy an a-Si TFT or CMOS FPD as the market has gradually shifted from CCD-II technology. A sizeable market still exists for CCD-II based systems, primarily due to lower system price points, however, the ongoing market conversion to FPD technology has led several CCD manufacturers to discontinue production due to concerns around the future demand for CCD-II technology. This includes Sony during 2017 and most recently, ON Semiconductor (the former Kodak CCD business) during 2020. Further advancements in CMOS technology are anticipated to contribute toward further replacement of the CCD-II technology in the coming years. In addition, the recent commercialization of detector technology predicated on Indium gallium zinc oxide (IGZO), creates an environment where an accelerated replacement of CCD-II technology is plausible. IGZO technology has long been perceived as a high potential technology due to the potential to develop higher performance and lower cost TFT FPDs, relative to a-Si. IGZO TFTs have superior electron mobility over a-Si TFT’s which enables for a smaller size TFT while also reducing the pixel discharge time, resulting in improved electronic noise performance (SNR) and speed. A smaller TFT size also enables improved performance at low doses in dynamic imaging. Data from the first commercialized IGZO FPDs demonstrate that IGZO is an excellent technology for medical system integrators and OEMs to adopt across a spectrum of clinical settings and it is anticipated that the adoption of this technology will accelerate.
- Historical global market sales data reported directly by OEMs under NDA
- Forecasted market sales data by product category, industry and geography
- Analysis of market sales growth by product category, industry and geography
- Accurate, credible and comprehensive market sales data
- Enrich your current view of the global market with the latest data and insight
- Understand the growth dynamics during 2021 and beyond
- Enhance decision making and strategic planning with reliable market analysis
- Improve forecasting
Collaboration with OEMs
In order to calculate market-level data, we are seeking to engage and collaborate with various component and system OEMs in order to support validating our global market estimates. These OEMs include:
Important note: OEM sales data shared with PMI is treated as strictly confidential and is not disclosed to any third-party source. OEM data is used exclusively to calculate the aggregate market size and market share data is not published within the output of this project.
Engage with industry stakeholders: the first stage is to engage with industry stakeholders to discuss and understand their needs from a research project. This process helps to create the desired data specifications and core deliverables.
Primary data collection: once the project scope is agreed upon, PMI seeks to collect sales data directly from OEMs under NDA agreement. Data directly submitted to PMI forms the basis of our market size calculations and ensures accurate market sizing estimates.
Discussion with OEMs and technology providers: alongside data collection, PMI seeks to engage senior executives in discussion around their perspectives on market growth dynamics. These include executives working within a strategy, market intelligence, product management as well as sales & marketing functions.
Secondary research: data is collected from secondary sources including financial reports, customs trade data, government institutions and regulators. This data is used to augment the data reported directly from OEMs to help validate market data points and assumptions.
Delivery and on-going analyst support: alongside the core deliverables, project delivery includes a presentation to highlight the key findings of the research, followed by a Q&A session to answer customer questions. Once the data and report are delivered, analyst support is provided to help customers maximise value from the project.
- Delivery of this report is expected to begin during H2 2021.
- The deadline for collaborating OEMs to change the data specification is the 30th April 2021.
- A 25% reduction of list prices is offered to OEM data contributors.
- A 25% reduction of list prices is offered to advanced purchases.
- The deadline for advanced purchase is the 30th April 2021.
|Each part available for purchase individually||List Price (GBP)||@ 25% discount|
|Part one: Excel data book: historical market data estimates||TBC||TBC|
|Part two: Excel data book: forecasted market data estimates||TBC||TBC|
|Part three: written report with analyst commentary||TBC||TBC|
Our Value Guarantee
We are passionate about delivering market and competitive intelligence to our clients. Our number one priority is to ensure that we are delivering value and that our clients are satisfied with our products and services. If you are not satisfied with the report or have a problem, we will solve it. This might mean providing you with additional research and insights or another body of analysis. We guarantee to our clients that we will add value.
PMI is an independent supplier of market intelligence and consultancy services to the global imaging technology industry. Our coverage areas include x-ray, ultrasound, magnetic resonance and nuclear imaging technologies. PMI is headquartered in Swindon, UK. PMI has become an authoritative source of market data and competitive intelligence within the x-ray detector industry.